Featured News

2014 NFID Fall Clinical Vaccinology Course scheduled for November 7-9, 2014 at the Houston Marriott at the Texas Medical Center in Houston, TX.

Early registration closes on September 29, 2014! Register before then to save $100.

Earn up to 19.75 hours of continuing education credit (CME, CNE, CPE).

Please click here for details and registration.

CLSI 2015 Antimicrobial Susceptibility Testing Update
February 4, 2015 or February 5 1015
1:00 - 2:30 PM ET 3:00 - 4:30 PM ET
Registration Deadline: February 2, 2015

Early Bird Pricing Available!
Register online by 1/7/15 to qualify.

DESCRIPTION
Each January, CLSI updates standards for antimicrobial susceptibility testing (AST). It is important for clinical laboratories to incorporate the new recommendations into routine practice to optimize detection and reporting of antimicrobial resistance. In January 2015, the annual update of the M100 tables (CLSI document M100-S25) will publish. In addition, there will be updates to the standards that describe performance of disk diffusion and MIC tests in versions M02-A12 and M07-A10, respectively. Some highlights for 2015 include introduction of the carbaNP test for carbapenemases and expanded recommendations for quality control testing. These changes and several other new recommendations found in M100-S25, M02-A12 and M07-A10 will be
discussed. In addition to the webinar, an optional postprogram self-assessment
will be provided that will allow individuals to assess their knowledge regarding the
most important AST and reporting issues for 2015. Laboratories can use this
feature to augment competency assessment requirements for their staff.

FACULTY
Janet A. Hindler, MCLS MT(ASCP), Sr. Specialist, Clinical Microbiology, UCLA Health System, Los Angeles, CA

AUDIENCE
This intermediate-level program is appropriate for laboratory professionals working in clinical and academic settings.

CONTINUING EDUCATION is available

REGISTRATION
Registration fee is per site for one connection to the live program with unlimited
attendance (and CEUs) for everyone AND unlimited access (and CEUs) to the archive program for 6 months

Early Bird Special $110: Register online by January 7, 2015
Regular fee: $125 when you register by registration form or online after January 7, 2015

Site facilitator must register online at www.aphl.org/courses/pages/588-950-15.aspx. Having difficulty with the online registration process? Please email registrar@aphl.org or call 240.485.2727 from 8:00 AM to 4:30 PM ET
. ET.

Triumeq (ABACAVIR SULFATE;DOLUTEGRAVIR;LAMIVUDINE)

was approved by the FDA on August 22nd, marking the second once daily integrase combination approved but without the drug interactions and intolerances associated with cobicistat in the QUAD pill.  Information from the SINGLE trial is available from the CROI 2014 meeting and a review of the agent in N Engl J Med. 2013;369:1807-1818.

After initial rejection in 2008, Oritavancin is approved today with the gateway indication for acute bacterial skin and skin structure infections (ABSSSI) caused by certain susceptible bacteria, including Staphylococcus aureus (including methicillin-susceptible and methicillin-resistant strains), various Streptococcus species and Enterococcus faecalis.  Oritavancin now joins dalbavancin, approved May 2014 and tedizolid approved June 2014 for similar indications, all with unique profiles.  The data exceeds this space so for more information, you can always review the CDER brief but objective review for dalbavancin and tedizolid. Review papers from the 2000s for oritavancin basics. Three new drugs courtesy of the GAIN act. Looking forward to the new beta lactamase inhibitor and cephalosporin for new gram negative pathogen options.

BACK TO THE PATIENT:
RE-FOCUSING ANTIMICROBIAL
STEWARDSHIP

SEPTEMBER 6, 2014
7:00 AM - 9:00 AM
MEETING ROOM 206
WALTER E. WASHINGTON CONVENTION CENTER
801 MT VERNON PLACE NW
WASHINGTON, DC

PRESENTERS
ANTHONY D. HARRIS, MD, MPH
Professor of Medicine
University of Maryland Medical Center, Baltimore, MD

This session will educate the clinician on how to identify patient centered outcomes to measure the performance of an ASP, including the feasibility of capturing such measures and consideration of the changing healthcare landscape in the era of healthcare reform.

CRAIG A. MARTIN, PHARMD, BCPS
Clinical Associate Professor
Department of Pharmacy Practice and Services
University of Kentucky College of Pharmacy, Lexington, KY

This session will inform the clinician on various types of quasiexperimental studies, including the advantages and disadvantages of each type and consideration of variability in resource availability.

For more information and to register, view the summary.

The Society of Infectious Diseases Pharmacists

2014 Call for Grant Applications to Fund Two

Infectious Diseases Pharmacotherapy Young Investigator

 Research Awards

 

The Society of Infectious Diseases Pharmacists (SIDP) is a dynamic association of health professionals dedicated to promoting the appropriate use of antimicrobials.  SIDP is committed to excellence in infectious diseases education, pharmacotherapy, and research.  One of the missions of SIDP is to promote research endeavors.

 

SIDP is soliciting ID pharmacotherapy research proposals from SIDP members who qualify as young investigators [£5 years from completion of their terminal training (e.g., residency, fellowship, graduate degree)].  The primary purpose of the research award is to provide funding for research projects that will contribute to the further development of the principal investigator’s research career and improve their competitiveness for future extramural funding.  Favorable consideration will be given to research proposals which focus on current pharmacotherapy issues surrounding the prevention and management of infectious diseases.

 

Proposals should be converted to a single PDF file adhering to the format described above. The PDF file of the proposal is then electronically submitted to both Stephanie Bulak (sbulak@eami.com) and the Chair of the Research Committee, David E. Nix (nix@pharmacy.arizona.edu).

 

Proposals must be submitted online no later than 5PM E.S.T. on Friday, August 8, 2014. 

 

For further details, click here.

The results of the election are in: Congratulations to the newly elected SIDP Board Members for 2014-15

President-Elect

Jason Gallagher

Secretary/Treasurer

Sandy Estrada

Board member-at-large

Craig Martin

Join us atop the skyline at the R2L restaurant in Center City Philadelphia at 

50 S. 16^th Street, 37^th Floor, Philadelphia, PA 6:00 to 8:00 pm. Details forthcoming.

Join us for our annual meeting in Washington, DC on September 5th at the Mandarin Oriental Hotel.  The business meeting and CE programming is planned to begin at noon with a reception to follow at 6:30pm. The fee for non-members/non-healthcare professionals including guests is $85 for the daytime meeting and evening reception or $50 for the evening reception alone.  Payments are accepted online via PayPal or credit card.

The agenda for the daytime meeting and CE information can be seen here. Final program logistics and details are coming.  Go to the events page for registration.